Estrogenic activity of furanocoumarins isolated from Angelica dahurica

Archives of Pharmacal Research

Volumn 29, Issue 9, 2006, Pages 741-745

  Xiang, Lan Piao ^a   Hye, Hyun Yoo ^b   Hyun, Young Kim ^c   Tak, Lim Kang ^d   Gwi, Seo Hwang ^e   Jeong, Hill Park ^c  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b Korea Institute of Science and Technology   (South Korea)

^c Seoul National University   (South Korea)

^d Daejeon University   (South Korea)

^e Gachon University   (South Korea)

Author keywords

Angelica dahurica; Estrogenic activity; Furanocoumarin; Umbelliferae

Indexed keywords

EID: 33749352946     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/bf02974073     Document Type: Article

References (30)

1. Bennett, E. L. and Bonner, J., Isolation of Plant Growth Inhibitors from Thamnosma Montana. Amer. J. Botany, 40, 29-33 (1953).
2. Bergendorff, O., Dekermendjian, K., Nielsen, M., Shan, R., Witt, R., Ai, J., and Sterner, O., Furanocoumarins with affinity to brain benzodiazepine receptors in vitro. Phytochemistry, 44, 1121-1124 (1997).
3. Bolton, J. L., Pisha, E., Zhang, F., and Qiu, S., Role of quinoids in estrogen carcinogenesis. Chem. Res. Toxicol., 11, 1113-1127 (1998).
4. Brosage, P., Hormone therapy: The woman's decision. Contemp. Nurse Pract., 1 (S), 3 (1995).
5. Colditz, G. A., Hankinson, S. E., Hunter, D. J., Willett, W. C., Manson, J. E., Stampfer, M. J., Hennekens, C., Rosner, B., and Speizer, F. E., The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. New Engl. J. Med., 332, 1589-1593 (1995).
6. Dreyer, D. L. and Lee A., Constituents of Cneoridium dumosum (Nutt.) Hook. F. Phytochemistry, 8, 1499-1501 (1969).
7. Edenharder, R., Speth, C., Decker, M., Kolodziej, H., Kayser, O., and Platt, K. L., Inhibition of mutagenesis of 2-amino-3-methylimidazo[4,5-f] quinoline (IQ) by coumarins and furanocoumarins, chromanones and furanochromanones. Mutat. Res., 345, 57-71 (1995).
8. Grodstein, F., Stamfer, M. J., Colditz, G. A., Willett, W. C., Manson, J. E., Joffe, M., Rosner, B., Fuchs, C., Hankinson, S. E., Hunter, D. J., Hennekens, C. H., and Speizer, F. E., Postmenopausal hormone therapy and mortality. New Engl. J. Med., 336, 1769-1775 (1997).
9. Harris, R. B., Laws, A., Reddy, F. M., King, A., and Haskell, W. L., Are women using postmenopausal estrogens? A community survey. Am. J. Public Health, 80, 1266-1268 (1990).
10. Henderson, B. E., Ross, R., and Bernstein, L., Estrogen as a cause of human cancer. The Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res., 48, 246-253 (1988).
11. Holinka, C. F., Hata, H., Kuramoto, H., and Gurpide, E., Effects of steroid hormones and antisteroids on alkaline phosphatase activity in human endometrial cancer cells (Ishikawa). Cancer Res., 46, 2771-2774 (1986).
12. Hsu, H. -Y., Chen, Y. -P., Shen, S. -J., Hsu, C. -C., and Chang, H. -C., Oriental Materia Medica: A Concise Guide. Oriental Healing Arts Institute, (1986).
13. Ishihara, K., Fukutake, M., Asano, T., Mizuhara, Y., Wakui, Y., Yanagisawa, T., Kamei, H., Ohmori, S., and Kitada, M., Simultaneous determination of byak-angelicin and oxypeucedanin hydrate in rat plasma by column-switching high-performance liquid chromatography with ultraviolet detection. J. of Chromatogra.B., 753, 309-314 (2001).
14. Kurzer, M. S. and Xu, X., Dietary phytoestrogens. Annu. Rev. Nutr., 17, 353-381 (1997).
15. Lee, S., Yoo, H. H., Piao, X. L., Kim, J. S., Kang, S. S., and Shin, K. H., Anti-estrogenic activity of lignans from Acanthopanax chiisanensis root. Arch. Pharm. Res., 28, 186-189 (2005)
16. Liehr, J. G., Genotoxic effects of estrogens. Mutat. Res., 238, 269-276 (1990).
17. Murkies, A. L., Wilcox, G., and Davis, S. R., Clinical review 92: Phytoestrogens. J. Clin. Endocrinol. Metab., 83, 297-303 (1998).
18. Nishida M., Kasahara K., Kaneko M., Iwasaki H., and Hayashi K., Establishment of a new human endometrial adenocarcinoma cell line, Ishikawa cells, containing estrogen and progesterone receptors. Nippon Sanka Fujinka Gakkai Zasshi, 37, 1103-1111 (1985).
19. Perry, L. M., Medicinal Plants of East and Southeast Asia: Attributed Properties and Uses. The MIT Press, Cambridge, (1980).
20. Piao, X. L., Baek, S. H., Park, M. K., and Park, J. H., Tyrosinase-inhibitory furanocoumarin from Angelica dahurica. Biol. Pharm. Bull., 27, 1144-1146 (2004).
21. Pisha, E. and Pezzuto, J. M., Cell-based assay for the determination of estrogenic and anti-estrogenic activities. Methods Cell Sci., 19, 37-43 (1997).
22. Saiki, Y., Morinaga, K., Okegawa, O., Sakai, S., Amaya, Y., Ueno, A., and Fukushima, S., On the Coumarins of the Root Agelica dahurica Benth. et Hook. Yakugaku Zasshi, 53, 1313-1317 (1971).
23. Setchell, K. D. R., Phytoestrogens: The biochemistry, physiology, and implications for human health of soy isoflavones. Am. J. Clin. Nutr., 68, 1333S-1346S (1998).
24. Setchell, K. D. R. and Cassidy, A., Dietary isoflavones: Biological effects and relevance to human health. J. Nutr., 129, 758S-767S (1999).
25. Stampfer, M. J., Willett, W. C., Hunter, D. J., and Manson, J. E., Type of postmenopausal hormone use and risk of breast cancer: 12-year follow-up from the Nurses' Health Study. Cancer Causes Control, 3, 433-439 (1992).
26. Stanley, W. L. and Vannier, S. H., Psoralens and substituted coumarins from expressed oil of lime. Phytochemistry, 6, 585-596 (1967).
27. Tang, W. and Eisenbrand, G., Chinese Drugs of Plant Origin, Chemistry, Pharmacology, and Use in Traditional and Modern Medicine. Springer, Berlin, (1992).
28. Wang, C. -C., Lai, J. -E., Chen, L. -G., Yen, K. -Y. and Yang, L. -L., Inducible nitric oxide synthase inhibitors of Chinese herbs. Part 2: Naturally occurring furanocoumarins. Bioorg. Med. Chem., 8, 2701-2707 (2000).
29. Wickelgren, I., Estrogen: A new weapon against Alzheimer's. Science, 276, 676-677 (1997).
30. Yoo, H. H., Kim, T., Ahn, S., Kim, Y. J., Kim, H. Y., Piao, X. L., and Park, J. H., Evaluation of the estrogenic activity of leguminosae plants. Biol. Pharm. Bull., 28, 538-540 (2005).